Jointly Provided by St. Joseph’s Hospital and Medical Center, MandatoryCE, LLC, and Arizona Pharmacy Association.


This activity is supported by an educational grant from Merck Sharp & Dohme Corp.


This activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding visit


This activity is supported by an educational grant from Valeritas, Inc.


Developed in collaboration with:

Arizona State Physicians Association

Arizona Latin-American Medical Association

Arizona LeadingAge

Arizona Diabetes Foundation



























































































































































































































Looking for CDC Publications? Search the Stacks!

Diabetes HealthSense


Links & Resources








































































































































































































































SW Diabetes



7:00am Registration and Breakfast in Exhibit Area
7:55am Welcome and Introduction
8:00am Update on the Epidemiology of Type 2 Diabetes Mellitus (T2DM) in the Southwestern US, Nationwide and Worldwide
8:15am Nutrition Therapy and Medical Management of Obesity
9:30am Managing Dyslipidemia: A Comparison of Current Lipid Guidelines and Treatment Recommendations
10:00am Recent Evidence of Diabetes Medications to Reduce Risk of Cardiovascular Disease and the Progression of Kidney Disease
10:30am Break and Refreshments in Exhibit Area
11:00am Overview of Current Antidiabetes Drug Classes, Treatment Guidelines, and Devices
11:30am Update on Emerging Pharmacotherapies: Focus on SGLT2s, Incretins, Insulins, and Combination Therapies
12:30pm Q&A Panel Discussion
1:00pm Adjourn




Target Audience
This activity is designed for family practice and other primary care physicians, endocrinologists, nurse practitioners, physician assistants, registered nurses, pharmacists, diabetes educators, registered dietitians, and other healthcare professionals who care for patients with type 2 diabetes mellitus (T2DM).

Learning Objectives
At the conclusion of this activity, participants should be better able to:

  1. Identify current statistics and future projections for type 2 diabetes mellitus (T2DM) in the southwestern US, nationwide, and worldwide.
  2. Recognize obesity as a chronic disease and utilize medical nutrition therapy as well as pharmacological approaches to support weight loss goals in patients with T2DM.
  3. Compare and contrast current lipid guidelines and treatment recommendations to improve lipid control in patients with dyslipidemia.
  4. Review the evidence and results from cardiovascular safety trials related to antidiabetes medications and their role in risk reduction for macrovascular complications and nephropathy.
  5. Summarize available drug classes and updated treatment guidelines for managing T2DM, which include efficacy, safety, and mechanisms of action.
  6. Evaluate the evidence of novel pharmacotherapies and apply best practices to fine-tune individualized treatment regimens that include SGLT2s, incretins, insulins, and combination therapies.

Activity Goal/Desired Result
Improved clinical performance through increased knowledge and utilization of current evidence-based treatments and guidelines; greater recognition and management of factors that have an impact on managing T2DM, including diet and nutrition, obesity, dyslipidemia, cardiovascular and kidney disease.

Summary of Identified Practice Gaps and Educational Needs
Statistics from the Centers for Disease Control and Prevention (CDC), report that over 30.3 million Americans are currently living with diabetes, and 84.1 million have prediabetes. Native Americans have the highest rate of diabetes among US adults (15.1%), followed closely by non-Hispanic blacks (12.7%) and Hispanics (12.1%). Arizona is ranked in the top five states with the highest percentage of Native Americans and Hispanics in the US, underscoring the burden of diabetes in this region.

In 2016, Arizona was ranked 21st in states reporting diabetes as an obesity-related health issue. Medical Nutrition Therapy (MNT) is a valuable adjunct to managing T2DM and obesity, however, most primary care practices do not have the benefit of in-house registered dietitians to facilitate patient evaluation and design treatment plans. In addition to MNT, there are now six FDA-approved anti-obesity drugs and clinical practice guidelines that present evidence for their use, although barriers continue to exist in the prescription of these pharmacotherapies.

Dyslipidemia and cardiovascular disease (CVD) are major causes of morbidity and mortality for individuals with diabetes. Appropriate use of current lipid and CVD guidelines and treatment recommendations will result in significant CVD risk reduction for adults with diabetes. Since 2008, nine completed trials have proven the cardiovascular safety profile of specific antidiabetes drugs, and another thirteen trials are currently underway. Thus far, two antidiabetes drugs have been FDA-approved to actually reduce the risk of cardiovascular disease in patients with T2DM and established CVD.

The plethora of pharmacotherapies to treat T2DM in patients with and without comorbidities is continually evolving. Added to this armamentarium are new formulations and combinations of existing drugs. To continually improve T2DM management in practice, it is imperative that clinicians remain current on recent treatment advances, updated indications, and the mechanisms of action for newer pharmacotherapies. These improvements in diabetes care offer innovative options to fine-tune individualized treatment regimens, lessen the potential for hypoglycemia, improve adherence, and help patients meet their treatment goals.

The 7th Annual Southwest Diabetes Symposium will present current information and evidence-based strategies on these topics. Clinicians will assess case studies using an interactive audience response system to increase knowledge, improve competence, and help facilitate change in performance and professional practice.

CME Accreditation and Designation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of St. Joseph’s Hospital and Medical Center, and MandatoryCE. St. Joseph’s Hospital and Medical Center is accredited by the ACCME to provide continuing medical education for physicians.

St. Joseph’s Hospital and Medical Center designates this live activity for a maximum of 4.5 AMA PRA Category 1 Credits™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

AAFP CME Credit 
This Live activity, 7th Annual Southwest Diabetes Symposium, with a beginning date of 09/15/2018, has been reviewed and is acceptable for up to  4.50 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE Credit 
This continuing nursing education activity was approved by the Western Multi-State Division, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation. (4.5 contact hours)

CDR Credit
This activity has been approved by the Commission on Dietetic Registration for 4.5 CPEUs.

ACPE CPE Credit 
The Arizona Pharmacy Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program has been approved for up to 4.5 contact hours (0.45 CEUs) of continuing pharmacy education credit by the Arizona Pharmacy Association, an ACPE-approved provider.



Faculty Bios and Disclosures

Roberto Ruiz, MD, FACP
Dr. Roberto Ruiz is a Doctor of Internal Medicine, as well as a Board Certified Internal Medicine Specialist. He is Diplomate of the American Board of Internal Medicine and a Fellow at the American College of Physicians. He operates his own practice; the Southwest Internal Medicine Group in Phoenix, Arizona.  Dr. Ruiz has been awarded recognition the past three years by the National Committee for Quality Assurance (NCQA), Diabetes Physician Recognition Program (DPRP).  He has also been awarded for the past three years by the National Committee for Quality Assurance (NCQA), and the American Heart Association/American Stroke Association by the Heart/Stroke Recognition Program (HSRP).  Since July 2008 his practice has been awarded recognition as an accredited Echocardiography Laboratory by the Intersocietal Commission for Accreditation of Echocardiography Laboratories (ICAEL).

He received his Doctor of Medicine at the Autonomous University of Guadalajara, Jalisco, Mexico 1975 to 1979 and did his Internship and Residency at Catholic Medical Center of Brooklyn, affiliated with Cornell Medical School.  He has 25 years professional experience as a Physician and Medical Director at St. Lukes Hospital, Physician Vascular Diagnostic Inc., International Medical Association Group and Del Carmel Hospital in Jalisco Mexico. He is presently an Adjunct Assistant Professor, Clinical Division, Midwestern University Arizona College of Osteopathic Medicine and serves on the Advisory Board of the College of Nursing, Grand Canyon University since 2005. In 2010, Dr. Ruiz accepted the position of Clinical Assistant Professor at University of Arizona, College of Medicine-Phoenix Campus. Dr. Ruiz also accepted the position of an Assistant Clinical Professor at Creighton University College of Medicine-Phoenix St. Joseph’s campus in 2012.

Disclosure: Roberto Ruiz, MD, FACP
Speakers Bureau: Janssen, Kowa, Merck
Consultant: Novo Nordisk


Philip Levy, MD, MACE
Dr. Levy is a clinical professor of medicine at the University of Arizona College of Medicine, and is chairman of the Section of Endocrinology and Metabolism at Banner Good Samaritan Regional Medical Center in Phoenix, Arizona, as well as past chief of staff and past chairman of medicine. He has practiced clinical endocrinology at Phoenix Endocrinology Clinic, LTD in Phoenix for more than 40 years. Dr. Levy graduated from the University of Pittsburgh School of Medicine in Pittsburgh, PA. He completed his internship, internal medicine residency, and fellowship in metabolism and endocrinology at Michael Reese Hospital and Medical Center in Chicago, Illinois. Dr. Levy was a research fellow in endocrinology at Guy’s Hospital Medical Center in London, England.

Dr. Levy served on the American Association of Clinical Endocrinologists (AACE) Board of Directors for six years, is past president of the American College of Endocrinology and currently serves as editor-in-chief of The First Messenger. He is past president and founding member of the board of directors of the Arizona Diabetes Association (ADA). Dr. Levy is an active member of AACE, American Medical Association and ADA in numerous capacities. He is a past member of The American Diabetes Association Board of Directors. He is also an Arizona Division of Motor Vehicles Medical Advisory Board Member, member of the Arizona Blue Shield, The Endocrine Society, American College of Physicians, Society of Nuclear Medicine, Arizona Medical Association, Clinical Endocrinology Editorial Board, and Endocrine Today Editorial Board. Dr. Levy is former Diabetes Forecast editor in chief and Clinical Diabetes editorial board member. He is a past editorial board member of Endocrine Practice. He is also a life member of the National Registry of Who’s Who.

Dr. Levy was presented the AACE Yank D. Coble, Jr., M.D., Distinguished Service Award in 2000 and the Master of the American College of Endocrinology Award in 2008.

Disclosure: Philip Levy, MD, MACE
Speakers Bureau: Janssen


Rosemarie Lajara, MD, FACE
Dr. Rosemarie Lajara is an endocrinologist with Diabetes Centers of America, Inc., in Plano, Texas, specializing in Endocrinology, Diabetes, and Metabolism. She is President of the Diabetes America Physicians Association and an active member of several scientific advisory boards and professional societies, including the American Association of Clinical Endocrinologists, the Endocrine Society and the American Diabetes Association. She trained as an Endocrinologist at Washington University School of Medicine in St Louis, Missouri where she continued her academic tenure after completing her fellowship. Currently she has an appointment with UT Southwestern as Clinical Associate Professor of Medicine.

Dr. Lajara’s contributions to her field span basic and clinical research including the characterization of the Insulin-like growth factor 1 gene as well as trials for many therapies and devices utilized to manage diabetes. She has authored multiple publications in prestigious medical journals, written textbook chapters, and served as editor for several medical journals. She has presented her work at many of the major endocrinology meetings including the Endocrine Society, AACE and ADA among others. Dr. Lajara is actively involved in professional medical education both nationally and internationally including initiatives from the Endocrine Society, ADA and the Institute for Diabetes and Cardiometabolic Diseases in which she has contributed to their curriculum development. She is also a member of the Guidelines Committee for the Endocrine Society.

Dr. Lajara is active in a number of public service initiatives in Texas, including the Mayor’s Passport to Health, in Dallas, which works to reduce the effects of diabetes in the community through education, awareness, prevention, and proper care management. In addition, she has been instrumental in developing programs and initiatives directed to improve the quality of care for patients with diabetes in at risk and underserved populations both nationally and internationally. Dr. Lajara has been the recipient of numerous honors and awards for her contributions in her field. In recognition of her patient care, she has been named to the National Committee for Quality Assurance Diabetes Physician Recognition Program.

Disclosure: Rosemarie Lajara, MD, FACE
Consultant: Novo Nordisk, Lilly, Sanofi, Valeritas
Speaker's Bureau: Novo Nordisk, Lilly, Sanofi, Valeritas


Krishnaswami Vijayaraghavan, MD, MS, FACC, FACP, FNLA, FHFSA
Dr. Vijay is the Medical Director of the Institute of Congestive Heart Failure at Abrazo Arizona Heart Institute and Hospital in Phoenix. He is a Non-invasive Cardiologist, a trained endocrinologist, clinical lipidologist, an ardent researcher and a Heart Failure specialist. He also holds a Master of Science degree in Clinical Research Design and Statistical Analysis from the University of Michigan.

He has been in clinical practice in Arizona for more than 27 years. Dr. Vijay is a past Governor of the American College of Cardiology, Arizona Chapter, Past President of the National Lipid Association, South West Chapter, current Executive Council Chair of National Lipid Association, a founding member and past President of the Cardio Renal Society of America and current President of the TWINEPIDEMIC, Inc., a nonprofit organization addressing Diabetes and Heart disease among Ethnic Communities all over the world. He is a Fellow of the American College of Cardiology, the American College of Physicians, National Lipid association and Heart Failure Society of America. He is a member of the clinical cardiology council as well as council for Atherosclerosis, Thrombosis and Vascular Biology at American Heart Association, a member of Prevention and Cardio-metabolic committee at American College of Cardiology and an Executive Board member of the National Lipid Association.

Dr. Vijay has participated in more than 180 clinical trials and his research is focused on such disorders as congestive heart failure, hypercholesterolemia, hypertension, coronary artery disease, plaque regression, Atrial Fibrillation, peripheral vascular disease and diabetes/metabolic syndrome. He has published numerous articles in peer reviewed journals. Dr. Vijay serves as a Clinical Professor of Medicine at University of Arizona, Phoenix and as an adjunct Professor of Medicine at Midwestern University Arizona College of Osteopathic Medicine (AZCOM).

Dr. Vijay is a founding member of the Arizona Managed Care Quality Enhancement Program (AMCQEP), 1992, and received the Governor’s award from Health Services Advisory Group (HSAG), October 2002, an innovation award through the Center for Health Innovation and Clinical Trial (CHI&CT) at Arizona State University from the President of Arizona State University in 2010 and the Jerome Markowitz award for a distinguished career from South Asian Society of Atherosclerosis and Thrombosis in 2013. He was one of the three nominees of Healthcare Heroes award for Phoenix Business Journal towards Life time achievement in 2017.He received a Lifetime achievement award from American College of Cardiology, Arizona Chapter in 2018.

He has presented at numerous national and International meetings on diabetes and heart disease. His professional activities also include serving on Editorial Boards of medical journals, reviewing and contributing towards landmark guidelines and policy statements as well as serving on many important advisory boards dealing with Quality initiatives of national organizations.

Disclosure: Krishnaswami Vijayaraghavan, MD, MS, FACC, FACP, FNLA, FHFSA
Honorarium/Expenses: Novartis, Amgen, AstraZeneca, Novo Nordisk, Boehringer Ingelheim
Advisory Board: Boehringer Ingelheim, Amgen, AstraZeneca


Craig Primack, MD, FACP, FAAP, FOMA
Dr. Craig Primack is a Diplomate of the American Board of Obesity Medicine ( and is board-certified in both internal medicine and pediatrics. Dr. Primack grew up in Chicago, Illinois. He attended the University of Illinois in Champaign for his undergraduate degree and received his MD from Loyola University Stritch School of Medicine in Chicago. He completed a combined residency in internal medicine and pediatrics at Banner University Phoenix and Phoenix Children’s Hospital in Phoenix, AZ.

He has served on the board of directors of the Obesity Medicine Association ( - the clinical leaders in Obesity Medicine who work to advance the prevention, treatment and reversal of the disease of obesity) since 2010. In 2017, he was elected as president-elect and his presidential term will begin in 2019. He has been a frequent speaker both nationally and internationally about all things regarding the disease state of obesity.

Dr. Primack is co-director and co-founder of the Scottsdale Weight Loss Center in Scottsdale, AZ. Scottsdale Weight Loss Center has five board certified Obesity Medicine physicians and four locations in Scottsdale, Chandler, Phoenix and Glendale, AZ.

Disclosure: Craig Primack, MD, FACP, FAAP, FOMA
Grant/Research Support: Novo Nordisk
Consultant: Nestle Nutrition
Speaker's Bureau: Novo Nordisk, Orexigen Therapeutics


Michelle Berman, MS, RDN, CDE, FAND
Michelle is a Registered Dietitian Nutritionist and co-owner of The Nutrition Professionals, a group dietitian practice in the Phoenix East Valley. Michelle is a Certified Diabetes Educator, a Fellow of The Academy of Nutrition of Dietetics and was the 2016 Arizona Outstanding Dietitian of the Year.

She is the Reimbursement Representative for The Academy of Nutrition and Dietetics Arizona affiliate and member of the AZAND Public Policy/Advocacy Committee. She is the resource for dietitians in Arizona who have questions about getting paid.

Michelle received her Bachelor of Arts Degree from California State University, Long Beach and a Master of Science Degree in Human Nutrition and Foods from Arizona State University. Michelle has worked in the field of health and nutrition in the Phoenix area since 1990. She is passionate about nutrition and feels that nutrition is the foundation for health and wellness. She realizes it takes a commitment to be healthy and fit. She practices what she teaches by eating healthfully, running, and practicing yoga. She enjoys cooking, hiking, and eating out. Michelle is a life-long learner and studies nutrition in her spare time.


  • Academy of Nutrition and Dietetics, Registered Dietitian Nutritionist
  • American Association of Diabetes Educators, Certified Diabetes Educator
  • Fellow of The Academy of Nutrition and Dietetics
  • Plant-Based Nutrition Certificate, eCornell and T. Colin Campbell Center for Nutrition Studies
  • Commission on Dietetic Registration, Certification in Adult Weight Management Levels 1 and 2
  • Academy of Nutrition and Dietetics, Certificate of Training in Chronic Kidney Disease Management
  • Arizona State University W.P. Carey School of Business, Leadership Certification

Disclosure: Michelle Berman, MS, RDN, CDE, FAND
Nothing to disclose.


Planning Committee

The following Planning Committee Members have stated they have nothing to disclose: 

Richard Vanderpool, CHCP
Veronica Baez
Kathy Harty
Christine Crowder, MD
Katherine Jorgensen, MSN/MBA, RN-BC, RNC-NIC, Hon.D 


Special Needs and ADA Compliance 

Persons with special needs or a disability may request a reasonable accommodation, such as a dietary choices, sign language interpreter, etc., by contacting Richard Vanderpool at 888-YourCE1 (888-968-7231) or Requests should be made as early as possible to allow time to arrange the accommodation.